Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | 29,517 | reported | 08 Dec 2025 | tx 180+678,990−471,467 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Dec 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 2,476 | 0.00 USD | |
| 08 Dec 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 1,396 | 712.94 USD | |
| 05 Dec 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 12,210 | 0.00 USD | deriv |
| 20 Nov 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 12,686 | 736.77 USD | |
| 20 Nov 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 14,450 | 555.67 USD | |
| 20 Nov 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 14,450 | 0.00 USD | deriv |
| 16 Dec 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 702 | 730.81 USD | |
| 06 Dec 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 2,332 | 0.00 USD | |
| 09 Dec 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 492 | 787.00 USD | |
| 06 Dec 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 8,981 | 0.00 USD | deriv |
| 11 Jul 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,866 | 1088.95 USD | |
| 24 Jun 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 11,084 | 1060.13 USD | |
| 24 Jun 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 14,450 | 555.67 USD | |
| 24 Jun 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 14,450 | 0.00 USD | deriv |
| 10 Jun 2024 | GIFT | REGENERON PHARMACEUTICALS, INC. | 1,608 | 0.00 USD | |
| 21 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,865 | 994.90 USD | |
| 26 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 990.00 USD | |
| 22 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 967.65 USD | |
| 07 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 950.00 USD | |
| 03 Jan 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 34,000 | 399.66 USD | |
| 03 Jan 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 24,493 | 912.30 USD | |
| 03 Jan 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 34,000 | 0.00 USD | deriv |
| 08 Dec 2023 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 852 | 843.79 USD | |
| 08 Dec 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 2,133 | 0.00 USD | |
| 11 Dec 2023 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 669 | 844.09 USD |